Related Experiment Video
Updated: Jun 29, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Management of Wilms tumor: current standard of care
Geoffrey Sonn1, Linda M D Shortliffe
1Stanford University Medical Center, Stanford, CA 94305-5118, USA.
Insights
Childhood Wilms tumor survival has dramatically improved to 90% due to multidisciplinary therapy. Current research focuses on reducing treatment-related morbidity, such as organ damage and secondary cancers.
Area of Science:
- Pediatric Oncology
- Pediatric Surgery
- Medical Malignancies
Background:
- Wilms tumor is the most common kidney cancer in children.
- Historically, survival rates were low (approx. 30% in the 1930s).
- Multidisciplinary therapy has significantly improved survival to about 90%.
Purpose of the Study:
- To compare the differing management strategies for Wilms tumor in Europe and the US.
- To highlight the current focus on reducing treatment-related morbidity.
- To assess the current role of laparoscopic surgery in Wilms tumor management.
Main Methods:
- Comparison of European (neoadjuvant chemotherapy followed by surgery) and US (primary surgery followed by chemotherapy) protocols.
- Review of outcomes and survival rates associated with different management strategies.
- Identification of significant treatment complications and current surgical limitations.
Main Results:
- Both European and US protocols achieve similar, excellent overall survival rates for Wilms tumor.
- Treatment complications include cardiomyopathy, renal failure, and secondary malignancies.
- The use of laparoscopic surgery in Wilms tumor management is currently very limited.
Conclusions:
- Wilms tumor management strategies in Europe and the US yield comparable high survival rates.
- The primary goal in Wilms tumor treatment has shifted towards minimizing long-term therapy-related side effects.
- Minimally invasive surgical approaches like laparoscopy have a restricted role in current Wilms tumor care.
Abstract:
Wilms tumor is the most common renal malignancy in children. In the 1930s, overall survival for children with Wilms tumor was approximately 30%. Use of multidisciplinary therapy, guided by results from multi-institutional, randomized trials, has substantially improved overall survival to about 90%. Management of Wilms tumor differs substantially between Europe and the US. In Europe, the International Society of Pediatric Oncology protocols call for management of patients with presumptive Wilms tumor with neoadjuvant chemotherapy followed by nephrectomy and further chemotherapy. In the US, protocols developed by the National Wilms Tumor Study Group advise primary nephrectomy followed by a chemotherapy regimen tailored to the pathologic tumor stage. Despite these disparate strategies, overall survival is similar in patients managed according to European and US protocols. Patients with Wilms tumor now have excellent survival. Therefore, current goals aim to reduce the morbidity associated with therapy. Important complications of treatment for Wilms tumor include cardiomyopathy, renal failure, and increased risk of a secondary malignancy. Currently, the role of laparoscopic surgery in management of Wilms tumor remains extremely limited.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Treatment Resistent Cancers
Kidney Transplant III: Nursing Management
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers